Table 2.
Characteristic | CLL
|
HL
|
NHL
|
NHL Patients With Available Data on Histopathologic Subtype*
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
High-Grade B-Cell NHL
|
Low-Grade B-Cell NHL
|
T-Cell/Anaplastic NHL
|
||||||||||
No. | % | No. | % | No. | % | No. | % | No. | % | No. | % | |
No. of patients | 7,749 | 7,476 | 25,801 | 2,297 | 4,359 | 615 | ||||||
Sex | ||||||||||||
Male | 5,134 | 66.3 | 4,515 | 60.4 | 14,988 | 58.1 | 1,333 | 58.0 | 2,365 | 54.3 | 392 | 63.7 |
Female | 2,615 | 33.7 | 2,961 | 39.6 | 10,813 | 41.9 | 964 | 42.0 | 1,994 | 45.7 | 223 | 36.3 |
Age group† | ||||||||||||
Younger patients | 3,764 | 48.6 | 4,419 | 59.1 | 12,550 | 48.6 | 1,198 | 52.2 | 2,278 | 52.3 | 302 | 49.1 |
Older patients | 3,985 | 51.4 | 3,057 | 40.9 | 13,251 | 51.4 | 1,099 | 47.9 | 2,081 | 47.7 | 313 | 50.9 |
Diagnosis year | ||||||||||||
1958-1967 | 554 | 7.1 | 852 | 11.4 | 1,277 | 4.9 | 0 | 0 | 8 | 0.2 | 0 | 0 |
1968-1977 | 1,130 | 14.6 | 1,905 | 25.5 | 3,522 | 13.7 | 5 | 0.2 | 16 | 0.4 | 6 | 0.98 |
1978-1987 | 2,448 | 31.6 | 2,179 | 29.1 | 7,309 | 28.3 | 528 | 23.0 | 1,069 | 24.5 | 89 | 14.5 |
1988-1998 | 3,617 | 46.7 | 2,540 | 34.0 | 13,693 | 53.1 | 1,764 | 76.8 | 3,266 | 74.9 | 520 | 84.6 |
Registry | ||||||||||||
Sweden | 5,927 | 76.5 | 5,047 | 67.5 | 19,651 | 76.2 | 1,054 | 45.9 | 2,480 | 56.9 | 351 | 57.1 |
Denmark | 1,822 | 23.5 | 2,429 | 32.5 | 6,150 | 23.8 | 1,243 | 54.1 | 1,879 | 43.1 | 264 | 42.9 |
Abbreviations: CLL, chronic lymphocytic leukemia; HL, Hodgkin's lymphoma; NHL, non-Hodgkin's lymphoma.
Information on histopathologic subtype was available for 7,271 (28.2%) of 25,801 NHL patients.
Age cut-offs for CLL, HL, and NHL (including NHL subtypes) were 67, 45, and 62 years, respectively.